Understanding the Persistence of Immune-mediated Chronic Diseases
了解免疫介导的慢性疾病的持续存在
基本信息
- 批准号:7849263
- 负责人:
- 金额:$ 226.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-30 至 2014-06-30
- 项目状态:已结题
- 来源:
- 关键词:AntigensAsthmaAutoimmune DiseasesAutoimmunityChronicChronic DiseaseChronic PhaseDiabetes MellitusDiseaseDisease remissionExcisionExposure toFlareGenerationsImmuneImmune System DiseasesImmune responseImmunityIndividualInfectionMediatingModelingMultiple SclerosisOutputPatternPharmaceutical PreparationsResearchStressSymptomsT-LymphocyteTestingTheophyllineTherapeutic InterventionThymus GlandTimeTissuesabstractingantimicrobialbasenovelpathogenprogramspsychologicpublic health relevance
项目摘要
DESCRIPTION (Provided by the applicant)
Abstract: Autoimmunity and asthma are immune-mediated diseases, which can last for the lifetime of an individual, causing financial, physical, psychological and societal burdens. Many of these diseases are characterized by symptomatic periods or flares, followed by a time of remission. Multiple factors, such as stress and infections, are believed to be responsible for this pattern. During these diseases, T cells are persistently stimulated by self or environmental antigens. Like autoimmune diseases, exposure to pathogens, which cause a chronic infection, also results in constant T cell stimulation by persistent antigens. I have recently demonstrated that new, pathogen-specific T cells are constantly produced during the chronic phase of infection, well after the initial infectious burst has resolved. This continued thymic output was required for maintaining the immune response. As common features can pertain to different immunological situations, the hypothesis to be tested in this proposal is whether the generation of T cells specific for tissue and environmental antigens in autoimmunity and asthma during established disease is a factor responsible for perpetuation of tissue damage. This hypothesis will be tested in different models of diabetes, multiple sclerosis and a novel model of asthma. In addition, manipulation of thymic output during these chronic diseases, as well as during chronic infections, will determine whether newly developed T cells can be programmed to dampen atopic or autoimmune diseases or augment anti-microbial immunity. If successful, these studies may offer a novel explanation for the chronicity of certain immunological diseases and provide a new paradigm on which to base therapeutic intervention.
Public Health Relevance: The research proposed here aims to understand how new T cells that are produced over time contribute to flares in symptoms of autoimmune diseases and asthma. This may also help us to understand why these diseases last a lifetime. Manipulation of newly produced T cells through drugs or removal of the thymus may result in a uniform treatment to interfere with multiple diseases and chronic infections.
描述(由申请人提供)
摘要:自身免疫和哮喘是免疫介导的疾病,可以持续一个人的一生,造成经济,身体,心理和社会负担。许多这些疾病的特点是症状期或耀斑,其次是一段时间的缓解。许多因素,如压力和感染,被认为是造成这种模式的原因。在这些疾病中,T细胞持续受到自身或环境抗原的刺激。与自身免疫性疾病一样,暴露于病原体(导致慢性感染)也会导致持久性抗原对T细胞的持续刺激。我最近证明,新的病原体特异性T细胞在感染的慢性阶段不断产生,在最初的感染爆发已经解决之后。这种持续的胸腺输出是维持免疫反应所必需的。由于共同的特征可能与不同的免疫学情况有关,因此在本提案中要检验的假设是,在已建立的疾病期间,在自身免疫和哮喘中,特异于组织和环境抗原的T细胞的产生是否是导致组织损伤永久化的因素。这一假设将在不同的糖尿病模型、多发性硬化症模型和一种新的哮喘模型中进行检验。此外,在这些慢性疾病以及慢性感染期间对胸腺输出的操纵将决定新开发的T细胞是否可以被编程以抑制特应性或自身免疫性疾病或增强抗微生物免疫。如果成功,这些研究可能为某些免疫性疾病的慢性化提供新的解释,并为治疗干预提供新的范例。
公共卫生相关性:本文提出的研究旨在了解随着时间的推移产生的新T细胞如何导致自身免疫性疾病和哮喘症状的爆发。这也可以帮助我们理解为什么这些疾病会持续一生。通过药物或切除胸腺来操纵新产生的T细胞可能会导致统一的治疗,以干扰多种疾病和慢性感染。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
VAIVA D VEZYS其他文献
VAIVA D VEZYS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('VAIVA D VEZYS', 18)}}的其他基金
Mechanisms of reduced T cell autoimmunity with immune experience
免疫经验降低T细胞自身免疫的机制
- 批准号:
10632556 - 财政年份:2022
- 资助金额:
$ 226.5万 - 项目类别:
Therapeutic vaccination targeting SIV viral reservoirs
针对 SIV 病毒库的治疗性疫苗接种
- 批准号:
8842310 - 财政年份:2014
- 资助金额:
$ 226.5万 - 项目类别:
Therapeutic vaccination targeting SIV viral reservoirs
针对 SIV 病毒库的治疗性疫苗接种
- 批准号:
8930062 - 财政年份:2014
- 资助金额:
$ 226.5万 - 项目类别:
相似海外基金
Defining new asthma phenotypes using high-dimensional data
使用高维数据定义新的哮喘表型
- 批准号:
2901112 - 财政年份:2024
- 资助金额:
$ 226.5万 - 项目类别:
Studentship
Air pollution and Asthma in Canada: Projections of burden and the value of climate adaptation strategies
加拿大的空气污染和哮喘:负担预测和气候适应战略的价值
- 批准号:
485322 - 财政年份:2023
- 资助金额:
$ 226.5万 - 项目类别:
Operating Grants
Data-driven model links BMIz to gene expression in pediatric asthma
数据驱动模型将 BMIz 与小儿哮喘基因表达联系起来
- 批准号:
493135 - 财政年份:2023
- 资助金额:
$ 226.5万 - 项目类别:
BIOlogic drug safety and effectiveness interNational pharmacoepidemiologIC study in pregnant women with autoimmune disorders and asthma and their children (BIONIC)
患有自身免疫性疾病和哮喘的孕妇及其子女的生物药物安全性和有效性国际药物流行病学研究(BIONIC)
- 批准号:
493526 - 财政年份:2023
- 资助金额:
$ 226.5万 - 项目类别:
Operating Grants
Engaging Patient and Caregivers in Using Patient-reported Outcomes Measures in Pediatric Clinical Care for Asthma
让患者和护理人员参与儿科哮喘儿科临床护理中患者报告的结果测量
- 批准号:
495593 - 财政年份:2023
- 资助金额:
$ 226.5万 - 项目类别:
Basophilic oncostatin M fuels nociceptor neuron-induced asthma
嗜碱性制瘤素 M 促进伤害感受器神经元诱发哮喘
- 批准号:
485504 - 财政年份:2023
- 资助金额:
$ 226.5万 - 项目类别:
Salary Programs
Mechanistic Study of Inspiratory Training in Childhood Asthma
儿童哮喘吸气训练机制研究
- 批准号:
10637048 - 财政年份:2023
- 资助金额:
$ 226.5万 - 项目类别:
Early life exposure to metal mixtures: impacts on asthma and lungdevelopment
生命早期接触金属混合物:对哮喘和肺部发育的影响
- 批准号:
10678307 - 财政年份:2023
- 资助金额:
$ 226.5万 - 项目类别:
Lung resident Treg suppression of Th2 resident memory T cells in allergic asthma
过敏性哮喘中肺常驻 Treg 对 Th2 常驻记忆 T 细胞的抑制
- 批准号:
10664599 - 财政年份:2023
- 资助金额:
$ 226.5万 - 项目类别:
Obesity and Childhood Asthma: The Role of Adipose Tissue
肥胖和儿童哮喘:脂肪组织的作用
- 批准号:
10813753 - 财政年份:2023
- 资助金额:
$ 226.5万 - 项目类别: